Andrés Iñiguez Romo

7PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCell physiologyCardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 07, 2025
Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Sergio Raposeiras-Roubín, Emad Abu Assi, César Jiménez Méndez

|Feb 25, 2025
Coronary Artery Disease in Very Young Women: Risk Factors and Prognostic Insights from Extended Follow-Up.

Samuel Pintos-Rodríguez, Víctor Alfonso Jiménez Díaz, César Veiga

|Jun 18, 2024
Health-Status Outcomes in Older Patients With Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy.

Gianluca Campo, Vincenzo Guiducci, Javier Escaned

|Aug 22, 2022
Clinical Features and Long-Term Outcomes in Very Young Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

Pablo Juan-Salvadores, Víctor Alfonso Jiménez Díaz, Ana Rodríguez González de Araujo

|Apr 30, 2019
Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial.

Andrés Iñiguez, Bernard Chevalier, Gert Richardt

|Mar 22, 2019
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.

Pilar Jimenez-Quevedo, Salvatore Brugaletta, Angel Cequier

Pageof 2